We are live on
!
Find out more
Intellia Therapeutics
NTLA
NTLA
302 hedge funds and large institutions have $1.42B invested in Intellia Therapeutics in 2026 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 127 increasing their positions, 63 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
164% more call options, than puts
Call options by funds: $60.6M | Put options by funds: $23M
102% more repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 63
51% more capital invested
Capital invested by funds: $938M → $1.42B (+$477M)
37% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 46
4% more funds holding
Funds holding: 291 → 302 (+11)
3.58% more ownership
Funds ownership: 89.95% → 93.53% (+3.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
302
Holders Change
+11
Holders Change %
+3.78%
% of All Funds
3.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
63
Increased
127
Reduced
63
Closed
46
Calls
$60.6M
Puts
$23M
Net Calls
+$37.6M
Net Calls Change
+$27.3M
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$25.6M |
| 2 |
BlackRock
New York
|
+$23.9M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$23.3M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$17.8M |
| 5 |
CGH
Contrarius Group Holdings
Hamilton,
Bermuda
|
+$15.3M |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$15M |
| 2 |
AC
Armistice Capital
New York
|
-$10.4M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$6.27M |
| 4 |
Barclays
London,
United Kingdom
|
-$4.64M |
| 5 |
HF
HRT Financial
New York
|
-$3.34M |
